EAM Investors’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-13,187	Closed	-$1.58M	–	323
2022 Q4	$1.58M	Sell	13,187 -166	-1%	-$19.4K	0.33%	136
2022 Q3	$1.42M	Buy	13,353 +2,041	+18%	+$207K	0.31%	140
2022 Q2	$1.1M	Buy	+11,312	New	+$1.04M	0.27%	177
2018 Q2	–	Sell	-41,529	Closed	-$3.44M	–	331
2018 Q1	$3.44M	Buy	41,529 +3,249	+8%	+$274K	0.57%	44
2017 Q4	$2.97M	Sell	38,280 -493	-1%	-$33.6K	0.53%	51
2017 Q3	$2.38M	Buy	+38,773	New	+$2.05M	0.32%	140
2016 Q3	–	Sell	-55,895	Closed	-$2.54M	–	338
2016 Q2	$2.54M	Sell	55,895 -25,489	-31%	-$1.17M	0.38%	133
2016 Q1	$3.22M	Buy	81,384 +5,171	+7%	+$205K	0.5%	49
2015 Q4	$4.31M	Buy	76,213 +18,502	+32%	+$940K	0.56%	30
2015 Q3	$2.3M	Sell	57,711 -13,421	-19%	-$649K	0.36%	125
2015 Q2	$3.4M	Buy	+71,132	New	+$3.02M	0.4%	90
2013 Q3	–	Sell	-180,478	Closed	-$2.42M	–	350
2013 Q2	$2.42M	Buy	+180,478	New	+$2.22M	0.52%	37